[Retracted] Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study

Table 4

Incidence of adverse reactions [].

	Fever	Fatigue	Thyroid dysfunction	Alopecia	Insomnia	Skin itching	Thrombocytopenia	Granulocytopenia
Group 2a ()	14 (33.33)	19 (45.24)	4 (9.52)	6 (14.29)	10 (23.81)	1 (2.38)	11 (26.19)	24 (57.14)
Group 2b ()	15 (35.71)	21 (50.00)	5 (11.90)	15 (35.71)	11 (26.19)	1 (2.38)	20 (47.62)	33 (78.57)
	0.053	0.191	0.124	5.143	0.063	—	4.141	4.421
	0.819	0.662	0.724	0.023	0.801	—	0.042	0.036